UnitedHealth Group Incorporated $UNH Shares Acquired by Sivik Global Healthcare LLC

Key Points

• Sivik Global Healthcare increased its UnitedHealth stake by 50% in the third quarter, acquiring 5,000 additional shares for a total of 15,000 shares valued at approximately $5.5 million. Institutional investors and hedge funds collectively own 87.86% of UNH.
• UnitedHealth reported third-quarter adjusted EPS of $4.69, beating the $4.14 consensus estimate, while revenue reached about $112.7 billion. Management raised its 2026 adjusted earnings outlook to at least $20.50 per share, citing lower medical costs and improved operating discipline.
• Despite stronger profitability, revenue declined 0.4% year over year, Optum Health revenue slipped and medical membership fell, underscoring concerns about slower top-line growth. UNH traded near $377.91, while analysts maintained a “Moderate Buy” consensus with an average price target of $462.59.

Sivik Global Healthcare LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 50.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,000 shares of the healthcare conglomerate's stock after purchasing an additional 5,000 shares during the quarter. UnitedHealth Group accounts for approximately 3.4% of Sivik Global Healthcare LLC's holdings, making the stock its 9th biggest position. Sivik Global Healthcare LLC's holdings in UnitedHealth Group were worth $5,506,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Sax Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 3.4% during the third quarter. Sax Wealth Advisors LLC now owns 2,378 shares of the healthcare conglomerate's stock valued at $873,000 after buying an additional 78 shares during the last quarter. NorthCrest Asset Manangement LLC grew its position in UnitedHealth Group by 41.3% during the third quarter. NorthCrest Asset Manangement LLC now owns 24,897 shares of the healthcare conglomerate's stock worth $9,235,000 after buying an additional 7,273 shares in the last quarter. Tilia Fiduciary Partners Inc. increased its stake in UnitedHealth Group by 3.1% during the third quarter. Tilia Fiduciary Partners Inc. now owns 7,237 shares of the healthcare conglomerate's stock valued at $2,657,000 after acquiring an additional 217 shares during the period. Argus Investors Counsel Inc. acquired a new position in UnitedHealth Group in the 3rd quarter valued at approximately $419,000. Finally, Castleview Partners LLC grew its holdings in shares of UnitedHealth Group by 3.4% during the 3rd quarter. Castleview Partners LLC now owns 9,191 shares of the healthcare conglomerate's stock worth $3,374,000 after purchasing an additional 303 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted earnings of $4.69 per share, well above estimates of roughly $4.12–$4.14 and substantially higher than the year-ago result. Revenue of approximately $112.7 billion also exceeded expectations. UnitedHealth Group tops estimates, hikes profit outlook
• Positive Sentiment: Third-quarter operating earnings increased 52% to $6.6 billion, supported by lower medical costs, tighter cost controls and improved execution across the insurance and Optum businesses. Management raised its 2026 adjusted earnings outlook to at least $20.50 per share, versus $18.15 in 2025. UnitedHealth raises 2026 earnings outlook
• Positive Sentiment: The results reinforce management’s turnaround strategy, including exiting unprofitable patient groups and improving operating discipline. Executives also suggested that investments in value-based care and artificial intelligence are beginning to contribute to performance. UnitedHealth: Huge Earnings Surprise
• Neutral Sentiment: Management indicated that Wall Street may be underestimating UnitedHealth’s 2027 earnings potential, but investors will likely need additional evidence that margin improvement can continue after the current recovery. UnitedHealth Says Wall Street May Be Underestimating Its 2027 Earnings Potential
• Negative Sentiment: Revenue was essentially flat year over year, with some reports showing a 0.4% decline, while Optum Health revenue slipped. Medical membership also fell, highlighting the trade-off between stronger margins and slower top-line growth. UnitedHealth’s Q3 2026 Sales Top Estimates
• Negative Sentiment: Although the earnings beat and guidance increase were significant, the initial enthusiasm faded, suggesting investors may have expected an even stronger outlook or more convincing evidence of sustained growth. UNH Earnings Beat and Raise Not Enough for Wall Street

UnitedHealth Group Price Performance

Shares of UNH traded down $0.61 during trading hours on Tuesday, hitting $377.91. The stock had a trading volume of 8,133,352 shares, compared to its average volume of 7,353,724. The stock has a market capitalization of $339.21 billion, a price-to-earnings ratio of 24.32, a P/E/G ratio of 1.43 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. The company's fifty day moving average is $388.03 and its two-hundred day moving average is $381.81. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm's revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.59 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 19.85 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group's payout ratio is presently 59.72%.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Morgan Stanley upped their target price on UnitedHealth Group from $468.00 to $529.00 and gave the company an "overweight" rating in a research note on Friday, July 17th. UBS Group reissued an "outperform" rating on shares of UnitedHealth Group in a report on Tuesday. Piper Sandler raised their price objective on shares of UnitedHealth Group from $477.00 to $499.00 and gave the stock an "overweight" rating in a report on Friday, July 17th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $370.00 to $467.00 and gave the company a "hold" rating in a research report on Friday, July 17th. Finally, Robert W. Baird raised shares of UnitedHealth Group from an "underperform" rating to a "neutral" rating and upped their target price for the company from $287.00 to $453.00 in a research note on Thursday, July 16th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $462.59.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.19% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.